Ping An Biomedical Co. Ltd. Class A (PASW)
NASDAQ: PASWConsumer DiscretionaryApparelUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
PASW stock chart
Technical analysisKey statistics
All statistics- Market cap
- $3.19M
- EPS (TTM)
- -$2.38
- Dividend yield
- None
- 52-week range
- 1.07 – 28.56
- Day range
- 1.13 – 1.34
- Volume / Avg
- 10.11K / 188.54K
- Beta
- —
- Shares outstanding
- 2.82M
52-week range
PASW stock today
Shares of Ping An Biomedical (PASW) finished lower on Nov 20 at $1.13, a drop of 10.32% or $0.13 per share, versus the S&P 500's 3.70% decline. Trading was light, with 10.11K shares changing hands, about 5% of the average daily volume. Shares are 96.0% below their 52-week high of $28.56 and 5.6% above the 52-week low of $1.07, near the bottom of the past year's range.
PASW is up 125.1% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 113.2%. Ping An Biomedical has posted a net loss over the last twelve months (EPS of -$2.38), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Ping An Biomedical
Company profilePing An Biomedical Co., Ltd., through its subsidiaries, provides supply chain management services in the apparel industry in China, Hong Kong, Cambodia, and Europe. The company offers market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management. It also engages in the manufacturing and trading of yarns, textiles, and finished garments; real estate property investment; and warehousing services.
- Sector
- Consumer Discretionary
- Industry
- Apparel
- CEO
- Mr. Pijun Liu
- Headquarters
- Cheung Sha Wan
- Employees
- 7
- IPO year
- 1999
- Website
- newbrandcashmere.com
Financial highlights
Full financialsIn fiscal 2025, Ping An Biomedical generated $4.8 million in revenue. Ping An Biomedical reported a net loss of $1.8 million. Gross margin was 2.8% and operating margin -43.1%.
| Fiscal year | FY 2025 |
|---|---|
| Revenue | $4.80M |
| Growth | — |
| Net income | $-1.80M |
| EPS (diluted) | $-0.10 |
PASW news
All PASW news- Ping An Biomedical Enters into Patent Purchase Agreement with Future Biotechnology Group for Tumor Cell TechnologiesGlobeNewswire
- Ping An Biomedical Enters into Patent Purchase Agreement with Future Biotechnology Group for Tumor Cell TechnologiesBusiness Insider
- Ping An Biomedical Announces Planned Acquisition of Three Tumor Cell-Related Medical Technology Patents to Build a Core Oncology and Biotech Intellectual Property PortfolioGlobeNewswire
- Ping An Biomedical Announces 1-for-40 Reverse Stock SplitGlobeNewswire
Ping An Biomedical peers
Consumer Discretionary sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| NCINeo-Concept International Group Holdings Limited Class A | 4.02 | -5.30% | $4.26M | vs PASW |
| FMFCKandal M Venture Limited Class A | 1.15 | -10.16% | $566.23K | vs PASW |
| BIRDSmartbird Inc. Class A | 1.07 | -7.79% | $12.76M | vs PASW |
| TLFTandy Leather Factory Inc. | 2.20 | +0.23% | $18.02M | vs PASW |
| BRIABrilliA Inc Class A | 1.40 | -5.47% | $34.98M | vs PASW |
| LANVLanvin Group Holdings Limited | 0.549 | +0.92% | $76.74M | vs PASW |
| JRSHJerash Holdings (US) Inc. | 7.01 | -2.64% | $89.03M | vs PASW |
| VRAVera Bradley Inc. | 4.96 | -8.32% | $142.30M | vs PASW |
Indexes, lists and sector
Largest Consumer Discretionary stocks
Ping An Biomedical stock FAQ
What is Ping An Biomedical's stock price today?
PASW last traded at $1.13 as of Nov 20, 4:00 PM EST, down 10.32% on the day. Prices are delayed at least 15 minutes.
Does Ping An Biomedical pay a dividend?
No. Ping An Biomedical does not currently pay a regular cash dividend.
Who is Ping An Biomedical's CEO?
Mr. Pijun Liu is the chief executive officer of Ping An Biomedical Co. Ltd. Class A, which has about 7 employees.
Has PASW ever split its stock?
Yes. The most recent PASW stock split was a 1-for-40 split on Oct 23, 2026.
What is the PASW 52-week high?
The 52-week high for PASW is $28.56 and the 52-week low is $1.07. The stock is currently 96.0% below its high.